About 100 Million Vaccine Doses Expected by Q3... 35 Million Doses Confirmed for Import by Next Month

On the 1st of last month, Moderna COVID-19 vaccines were being delivered to the vaccine storage room at GC Green Cross Ochang Plant in Cheongju, Chungbuk. In South Korea, GC Green Cross is responsible for the distribution of Moderna vaccines.
/Photo by Joint Press Corps

[Asia Economy Reporter Lee Chun-hee] A total of 35 million vaccine doses will be introduced domestically by next month. Including the 42 million doses to be introduced in September, the total number of vaccines introduced domestically by the third quarter will reach approximately 100 million doses.

Baek Gyeong-taek, Head of the Central Disease Control Headquarters Situation Management Team, stated, "About 35 million doses of vaccines are scheduled to be supplied from the 16th to the end of August," adding, "Specifically, 27 million doses in August and 42 million doses in September are expected to be supplied." Considering that a total of 21.5 million doses have already been introduced, a total of 98.5 million doses will be introduced domestically by the third quarter.

Currently, the government has promised to introduce a total of 193 million vaccine doses within this year with various pharmaceutical companies and the 'COVAX Facility.' Among these, the vaccines already introduced are ▲AstraZeneca (AZ) 10,081,000 doses ▲Pfizer 9,543,000 doses ▲Moderna 862,000 doses ▲Janssen 1,013,000 doses, totaling 21,499,000 doses.

In addition, by the end of next month, the plan is to complete the introduction of a total of 34,936,000 doses, including 835,000 doses of AZ (COVAX supply), 101,000 doses of Janssen, and 34 million doses from direct contracts with AZ, Pfizer, and Moderna.

Of these, about 7 million doses are planned to be introduced within this month. However, regarding the specific vaccine types and introduction schedules, Baek Young-ha, Head of the Government-wide Vaccine Introduction T/F Vaccine Introduction General Team, explained, "We will continuously inform you within the scope that can be disclosed later," adding that detailed introduction schedules are difficult to disclose due to confidentiality agreements with pharmaceutical companies.

However, Baek emphasized, "The 10 million doses scheduled for introduction in July are currently planned to be fully introduced within July," and "Discussions with pharmaceutical companies regarding the monthly volume for August have been completed." While detailed weekly supply volumes and schedules are difficult to disclose, the overall monthly introduction volumes have been confirmed.

This content was produced with the assistance of AI translation services.